GLP-1 S

GLP-1S is a research-grade injectable formulation, designed for experimental studies on metabolic regulation, appetite modulation, and glucose homeostasis in preclinical models. This GLP-1S receptor agonist targets incretin pathways to explore insulin secretion enhancement, gastric emptying delay, and energy expenditure effects in obesity and diabetes research.

Core Benefits

• Mimics endogenous GLP-1 to stimulate glucose-dependent insulin release and suppress glucagon, with studies showing improved glycemic control and beta-cell preservation in metabolic disorder models.

• Promotes satiety signaling via hypothalamic pathways, reducing food intake and supporting body composition optimization observed in weight management investigations.

• Enhances cardiovascular and renal protective mechanisms, including reduced inflammation and oxidative stress, as evidenced in long-term endocrine research trials.

For research purposes only. Not intended for human consumption.